Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
ACLXArcellx	$3.51bn	n/a	n/a
CRSPCrispr Therapeutics AG	$3.31bn	n/a	n/a
AKROAkero Therapeutics	$3.26bn	n/a	n/a
SRRKScholar Rock Holding	$3.11bn	n/a	n/a
CRNXCrinetics Pharmaceuticals	$3.03bn	n/a	n/a
MRUSMerus NV	$3.01bn	n/a	n/a
KDNYChinook Therapeutics	$2.90bn	n/a	n/a
XENEXenon Pharmaceuticals	$2.88bn	n/a	n/a
MORFMorphic Holding	$2.86bn	n/a	n/a
VKTXViking Therapeutics	$2.81bn	n/a	n/a
PTGXProtagonist Therapeutics	$2.73bn	10.52	n/a
MLTXMoonLake Immunotherapeutics	$2.53bn	n/a	n/a
VCYTVeracyte	$2.51bn	92.29	n/a
IMVTImmunovant	$2.50bn	n/a	n/a
ACADAcadia Pharmaceuticals	$2.46bn	25.03	n/a
ALVOAlvotech SA	$2.40bn	n/a	n/a
LBPHLongboard Pharmaceuticals	$2.34bn	n/a	n/a
RXRXRecursion Pharmaceuticals	$2.30bn	n/a	n/a
IBRXImmunitybio	$2.30bn	n/a	n/a
DNLIDenali Therapeutics	$2.28bn	n/a	n/a